HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA-DR associations with Graves' disease in eastern Hungary.

Abstract
We have typed 196 patients with Graves' disease from eastern Hungary (an iodine-deficient region) for HLA-A, -B, and -C antigens and 80 of the same patients for HLA-DR antigens. Our data confirm the previously described association of HLA-B8 and DR3 with Graves' disease, particularly in patients with ophthalmopathy. We also describe several new findings: an increase in the prevalence of HLA-BW35, particularly in combination with B8, among patients with ophthalmopathy and a slight increase in the prevalence of B8, DR7 among patients with ophthalmopathy. These results support the concept that MHC-linked susceptibility to Graves' disease is dose-dependent. Our results do not confirm a report suggesting that the prevalence of HLA-DR5 is increased among patients without ophthalmopathy in iodine-deficient areas: we found that the prevalence of HLA-DR5 was slightly decreased among patients with Graves' disease, with and without ophthalmopathy, in comparison with controls.
AuthorsV Stenszky, L Kozma, C Balazs, N R Farid
JournalClinical and investigative medicine. Medecine clinique et experimentale (Clin Invest Med) Vol. 6 Issue 3 Pg. 181-4 ( 1983) ISSN: 0147-958X [Print] Canada
PMID6580983 (Publication Type: Journal Article)
Chemical References
  • HLA-DR Antigens
  • Histocompatibility Antigens Class II
  • Iodine
Topics
  • Eye Diseases (complications, immunology)
  • Graves Disease (complications, immunology)
  • HLA-DR Antigens
  • Histocompatibility Antigens Class II (analysis)
  • Humans
  • Hungary
  • Iodine (deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: